GENE ONLINE|News &
Industrializing iPSC and Harnessing its Medical Applications – An Interview with Dr. Hong-Lin Su
Featured in the special topic of Gene and Cell Therapy, GeneOnline is honored to interview Professor Hong-Lin Su from the Department of Life Sciences at National Chung Hsing University, who is one of the few induced pluripotent stem cell (iPSC) experts in the field of cell therapy in Taiwan, with experience in academia, industry, and clinical practice.
The technology of neural differentiation from pluripotent stem cells developed by Prof. Su’s team not only won the National Innovation Award in 2017 but was also successfully patented in Taiwan, the US, and Japan. During the interview, Prof. Su introduced the principle of iPS cell therapy and its current clinical applications. He also shared his rich experience accelerating the formation of Taiwan's cell therapy industry chain by establishing DuoGenic Stem Cells in recent years.
The technology of neural differentiation from pluripotent stem cells developed by Prof. Su’s team not only won the National Innovation Award in 2017 but was also successfully patented in Taiwan, the US, and Japan. During the interview, Prof. Su introduced the principle of iPS cell therapy and its current clinical applications. He also shared his rich experience accelerating the formation of Taiwan's cell therapy industry chain by establishing DuoGenic Stem Cells in recent years.
It's free! Log in now to read
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
